Walgreens Boots Alliance (NASDAQ:WBA) was upgraded by TheStreet from a “c+” rating to a “b” rating in a research note issued on Wednesday.

A number of other equities research analysts also recently issued reports on WBA. BidaskClub raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Wednesday. Robert W. Baird upped their target price on Walgreens Boots Alliance from $64.00 to $69.00 and gave the stock a “neutral” rating in a research report on Tuesday. Cowen downgraded Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 target price for the company. in a research report on Monday, July 23rd. Citigroup downgraded Walgreens Boots Alliance from a “buy” rating to a “neutral” rating and set a $69.00 target price for the company. in a research report on Monday, July 9th. Finally, Pivotal Research decreased their target price on Walgreens Boots Alliance from $70.00 to $60.00 and set a “hold” rating for the company in a research report on Monday, July 2nd. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $76.61.

Shares of NASDAQ:WBA traded down $0.15 during midday trading on Wednesday, reaching $70.33. The company’s stock had a trading volume of 48,567 shares, compared to its average volume of 4,756,452. The company has a market cap of $69.85 billion, a P/E ratio of 13.84, a P/E/G ratio of 1.07 and a beta of 1.09. The company has a quick ratio of 0.47, a current ratio of 0.93 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance has a 1 year low of $59.07 and a 1 year high of $83.74.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 28th. The pharmacy operator reported $1.53 EPS for the quarter, beating the Zacks’ consensus estimate of $1.47 by $0.06. The business had revenue of $34.33 billion during the quarter, compared to the consensus estimate of $34.15 billion. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The business’s revenue for the quarter was up 14.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.33 earnings per share. sell-side analysts expect that Walgreens Boots Alliance will post 5.97 earnings per share for the current fiscal year.

In related news, insider Stefano Pessina purchased 1,697,438 shares of the company’s stock in a transaction dated Monday, July 16th. The shares were acquired at an average cost of $63.92 per share, for a total transaction of $108,500,236.96. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total value of $180,548.64. Following the sale, the director now owns 10,943 shares in the company, valued at $722,128.57. The disclosure for this sale can be found here. Corporate insiders own 14.80% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. Archford Capital Strategies LLC acquired a new stake in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $115,000. BlueMountain Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $103,000. CSat Investment Advisory L.P. acquired a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $104,000. Squar Milner Financial Services LLC acquired a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $106,000. Finally, Kaizen Advisory LLC raised its position in shares of Walgreens Boots Alliance by 128.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after purchasing an additional 1,083 shares during the period. Institutional investors and hedge funds own 61.98% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Featured Story: What is a Fiduciary?

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.